Observational study of COVID-19 prophylactic antibody (tixagevimab/cilgavimab) administration for multiple myeloma patients

被引：0
|
作者：
Lee, Yoojin [1 ,2 ]
Jo, Jae-Cheol [1 ]
机构：
[1] Ulsan Univ Hosp, Ulsan, South Korea
[2] Univ Ulsan, Coll Med, Ulsan, South Korea
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-469
引用
收藏
页码：S298 / S298
页数：1
相关论文
共 50 条
  • [1] Tixagevimab/Cilgavimab as Pre-Exposure Prophylaxis against COVID-19 for Multiple Myeloma Patients: A Prospective Study in the Omicron Era
    Ntanasis-Stathopoulos, Ioannis
    Filippatos, Charalampos
    Gavriatopoulou, Maria
    Malandrakis, Panagiotis
    Eleutherakis-Papaiakovou, Evangelos
    Spiliopoulou, Vassiliki
    Syrigou, Rodanthi-Eleni
    Theodorakakou, Foteini
    Fotiou, Despina
    Migkou, Magdalini
    Roussou, Maria
    Kastritis, Efstathios
    Dimopoulos, Meletios Athanasios
    Terpos, Evangelos
    DISEASES, 2023, 11 (03)
  • [2] Prophylactic effect of tixagevimab–cilgavimab on COVID-19 infection and death in Japanese patients with B cell lymphoma
    Hiro Tatetsu
    Yusuke Higuchi
    Takafumi Shichijo
    Kazutaka Oda
    Hirotomo Nakata
    Jun-ichirou Yasunaga
    Kisato Nosaka
    Masao Matsuoka
    International Journal of Hematology, 2023, 118 : 303 - 305
  • [3] Tixagevimab-Cilgavimab for Breakthrough COVID-19 Prevention in Dialysis Patients: A Prospective Study
    Sritippayawan, Suchai
    Boongird, Sarinya
    Srithongkul, Thatsaphan
    Sethakarun, Sethanant
    Bruminhent, Jackrapong
    Kiertiburanakul, Sasisopin
    Nongnuch, Arkom
    Kitiyakara, Chagriya
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [4] Tixagevimab-cilgavimab for preventing breakthrough COVID-19 in dialysis patients: a prospective study
    Boongird, Sarinya
    Srithongkul, Thatsaphan
    Sethakarun, Sethanant
    Bruminhent, Jackrapong
    Kiertiburanakul, Sasisopin
    Nongnuch, Arkom
    Kitiyakara, Chagriya
    Sritippayawan, Suchai
    CLINICAL KIDNEY JOURNAL, 2024, 17 (11)
  • [5] Prophylactic effect of tixagevimab-cilgavimab on COVID-19 infection and death in Japanese patients with B cell lymphoma
    Tatetsu, Hiro
    Higuchi, Yusuke
    Shichijo, Takafumi
    Oda, Kazutaka
    Nakata, Hirotomo
    Yasunaga, Jun-Ichirou
    Nosaka, Kisato
    Matsuoka, Masao
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (02) : 303 - 305
  • [6] A case of prolonged COVID-19 treated with tixagevimab/cilgavimab
    Shimizu, Takahiro
    Shirasaki, Hiroki
    Okafuji, Kazuhiro
    Sawazaki, Aiko
    Iwabuchi, Tasuku
    Matubayashi, Ryo
    RESPIROLOGY CASE REPORTS, 2023, 11 (03):
  • [7] Tixagevimab/cilgavimab for prevention and treatment of COVID-19: a review
    Ustianowski, Andrew
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2022, 20 (12) : 1517 - 1527
  • [8] Belt and Suspenders: Vaccines and Tixagevimab/Cilgavimab for Prevention of COVID-19 in Immunocompromised Patients
    Kotton, Camille N.
    ANNALS OF INTERNAL MEDICINE, 2022, 175 (06) : 892 - +
  • [9] Pre-exposure prophylaxis for COVID-19 with tixagevimab/cilgavimab (evusheld) in patients with multiple myeloma in the omicron SARS-COV-2 era
    Ntanasis-Stathopoulos, Ioannis
    Gavriatopoulou, Maria
    Eleutherakis-Papaiakovou, Evangelos
    Malandrakis, Panagiotis
    Spiliopoulou, Vassiliki
    Syrigou, Rodanthi-Eleni
    Theodorakakou, Foteini
    Fotiou, Despina
    Migkou, Magdalini
    Roussou, Maria
    Kastritis, Efstathios
    Dimopoulos, Meletios
    Terpos, Evangelos
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S302 - S303
  • [10] Tixagevimab/Cilgavimab for Prevention of Covid-19 in Newly Transplanted Kidney Recipients
    El Chediak, A.
    Bruns, C.
    Simard, R.
    Spence, K.
    Forbes, R.
    Concepcion, B. P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : S661 - S662
12345